USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-03-18 обновлены отчеты компании ABEO: 20232022
Abeona Therapeutics logo
Abeona Therapeutics ABEO
$ 4.6 13.02%

Abeona Therapeutics Мультипликаторы 2011-2024 | ABEO

Мультипликаторы по годам Abeona Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-2.8 -0.6 -0.0 -2.1 -1.6 -5.5 -23.3 -7.2 -5.0 -0.2 2.0 -1.1 -10.7

P/S

42.7 15.5 0.3 17.7 - 104.5 761.1 176.9 69.3 6.6 4.5 2.6 14.6

EPS

-2.5 -5.5 -21.6 -0.9 -1.5 -1.2 -0.7 -0.6 -0.5 -15.3 3.1 -0.5 -0.2

EV (Enterprise Value)

184 млн 45.2 млн 5.3 млн 213 млн 35 млн 335 млн 508 млн 100 млн 44.2 млн 6.35 млн 24.1 млн 29.8 млн 45.9 млн

EBITDA per Share

-2.1 -6.08 -22 -0.474 -1.38 -1.17 -0.651 -0.675 -0.652 -1.61 -7.53 -8.06 -19.1

EV/EBITDA

0.1 -3.8 0.1 -5.8 -18.4 -3.8 -2.0 0.3 -2.3 -2.8 -3.6

PEG

-0.0 -0.0 -0.0 -0.05 0.06 0.07 7.46 0.35 -0.05 0.0 0.02 0.01 -0.17

P/B

10.1 0.8 0.0 1.7 0.7 2.3 3.7 1.6 1.1 1.3 -0.6 -0.7 -1.5

P/CF

-4.0 -0.5 -0.0 -4.9 -1.7 -5.3 -26.8 -11.6 -6.7 -3.8 -9087.5 -2.9 -3.5

ROE %

-365.49 -148.34 -200.47 -82.14 -42.75 -42.28 -16.06 -22.07 -21.45 -556.02 -30.10 61.68 14.38

ROA %

-84.67 -61.82 -106.72 -55.71 -34.15 -32.50 -15.28 -19.70 -18.15 -161.49 725.77 -608.79 -66.90

ROCE %

-317.92 -190.26 -212.04 -44.40 -41.74 -37.76 -16.08 -23.24 -23.60 -22.88 45.57 88.10 93.71

Current Ratio

1.3 1.7 2.1 2.3 3.4 4.4 25.1 8.4 27.5 4.0 0.1 0.3 0.3

DSO

- 387.2 182.5 - - 9.9 46.7 50.9 40.4 13.8 13.2 69.6 65.8

DIO

- - - - - - - - - - - 265.2 45.3

DPO

- - - - - - - - - - 2520.0 2787.4 514.2

Операционный цикл

- 387.2 182.5 - - - - - - - 13.2 334.8 111.1

Финансовый цикл

- 387.2 182.5 - - - - - - - -2506.7 -2452.6 -403.1

Все данные представлены в валюте USD

Мультипликаторы поквартально Abeona Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.48 0.92 -0.54 - -1 1.36 -3.8 - -1.8 -3.93 -0.17 - -0.08 -0.14 -0.52 -0.3 -0.35 -0.49 -0.39 -0.36 -0.34 -0.26 -0.22 -0.19 -0.13 -0.21 -0.13 - -0.08 -0.2 -0.17 - -0.19 -0.16 -0.1 - -4.15 -0.51 -0.03 - -1.77 0.03 0.14 - -0.63 -0.46 -0.22 - - -0.09 -0.12

EBITDA per Share

-0.44 -0.55 -0.67 - -1.34 -1.24 -3.41 - -3.17 -3.12 -0.15 - -0.06 -0.13 -0.5 -0.3 -0.31 -0.45 -0.36 -0.38 -0.34 -0.26 -0.22 -0.19 -0.13 -0.2 -0.13 - -0.15 -0.2 -0.18 - -0.19 -0.16 -0.09 - -1.19 -0.03 -0.05 - -1.37 -0.08 -0.02 - -0.04 -0.06 -0.03 - -0.09 -0.11 -0.11

ROE %

-332.40 -330.58 -181.58 -185.16 -193.99 -150.95 -139.82 -43.87 -50.93 -49.15 -43.75 -66.70 -75.91 -78.59 -79.31 -42.75 -46.58 -49.10 -44.82 -42.28 -34.21 -25.10 -20.83 -16.06 -13.74 -13.25 -15.14 -15.01 -23.97 -30.29 -29.60 -17.99 -48.50 -70.03 -323.66 -308.04 -306.97 -275.41 -26.54 -37.38 49.69 135.69 208.59 177.79 175.80 86.75 31.85 15.98 -1.99 7.18 10.79

ROA %

-82.68 -81.37 -59.43 -65.72 -71.63 -60.95 -63.43 -28.87 -33.66 -32.52 -29.49 -45.24 -52.60 -55.59 -57.69 -34.15 -36.82 -38.45 -34.76 -32.50 -27.20 -20.77 -18.38 -15.28 -12.92 -12.29 -13.70 -13.39 -20.98 -26.20 -25.30 -15.22 -24.08 -25.35 -95.64 -89.46 -115.08 -131.83 204.61 901.14 41.78 -791.97 -1665.70 -1754.86 -1745.61 -877.00 -297.68 -74.32 9.25 -33.39 -50.17

ROCE %

-304.24 -328.45 -272.62 -229.95 -248.60 -191.61 -150.82 -50.42 -56.52 -43.96 -39.82 -65.27 -74.47 -78.27 -79.54 -43.20 -47.44 -50.17 -46.10 -43.39 -35.10 -25.63 -21.23 -16.36 -16.44 -18.51 -20.32 -18.21 -27.32 -31.20 -30.51 -18.15 -31.30 -35.34 -43.84 -55.32 -50.61 -32.75 -5.16 21.11 26.71 27.60 23.10 18.14 28.27 32.80 37.10 35.14 10.13 12.80 12.21

Current Ratio

1.5 1.2 1.5 1.7 1.7 1.8 2.3 2.8 3.0 2.8 3.0 3.1 3.1 3.1 3.1 5.0 5.0 5.0 5.0 4.3 4.3 4.3 4.3 20.6 20.6 20.6 20.6 9.3 9.3 9.3 9.3 6.5 6.5 6.5 6.5 1.4 1.4 1.4 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2

DSO

- - - - 69.4 45.6 395.6 - - - - - 45.6 - - - - - - - 4.3 26.8 3.3 - 44.6 45.0 56.7 - 61.5 52.9 46.4 - 36.8 37.2 26.5 - 13.5 12.9 23.9 - 35.7 14.5 34.1 - 88.0 111.1 29.1 - 29.2 202.6 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - 69.4 45.6 395.6 - - - - - 45.6 - - - - - - - 4.3 26.8 3.3 - 44.6 45.0 56.7 - 61.5 52.9 46.4 - 36.8 37.2 26.5 - 13.5 12.9 23.9 - 35.7 14.5 34.1 - 88.0 111.1 29.1 - 29.2 202.6 -

Финансовый цикл

- - - - 69.4 45.6 395.6 - - - - - 45.6 - - - - - - - 4.3 26.8 3.3 - 44.6 45.0 56.7 - 61.5 52.9 46.4 - 36.8 37.2 26.5 - 13.5 12.9 23.9 - 35.7 14.5 34.1 - 88.0 111.1 29.1 - 29.2 202.6 -

Все данные представлены в валюте USD